{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:33:53Z","timestamp":1740123233956,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"General Research Fund, Research Grant Council of Hong Kong","award":["17122417"],"award-info":[{"award-number":["17122417"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11033-022-07902-3","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T14:27:56Z","timestamp":1663252076000},"page":"11201-11208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Contribution of ENT4 to adenosine uptake in AC16 human cardiomyocytes under simulated ischemic conditions and its potential role in cardioprotection"],"prefix":"10.1007","volume":"49","author":[{"given":"Emily Sze-Wan","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renkai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polly Ho-Ting","family":"Shiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panthakarn","family":"Rangsinth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai-Wang","family":"Seto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3529-9367","authenticated-orcid":false,"given":"George Pak-Heng","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"issue":"1","key":"7902_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/1074248410396877","volume":"17","author":"VJ McIntosh","year":"2012","unstructured":"McIntosh VJ, Lasley RD (2012) Adenosine receptor-mediated cardioprotection: Are all subtypes required or redundant? J Cardiovasc Pharmacol Ther 17(1):21?33","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"7902_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.clpt.2005.03.003","volume":"78","author":"NP Riksen","year":"2005","unstructured":"Riksen NP, Oyen WJ, Ramakers BP, Van den Broek PH, Engbersen R, Boerman OC, Smits P, Rongen GA (2005) Oral therapy with dipyridamole limits ischemia?reperfusion injury in humans. Clin Pharmacol Ther 78(1):52?59","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"7902_CR3","doi-asserted-by":"publisher","first-page":"H2921","DOI":"10.1152\/ajpheart.01191.2005","volume":"292","author":"Z Zhu","year":"2007","unstructured":"Zhu Z, Hofmann PA, Buolamwini JK (2007) Cardioprotective effects of novel tetrahydroisoquinoline analogs of nitrobenzylmercaptopurine riboside in an isolated perfused rat heart model of acute myocardial infarction. Am J Physiol Heart Circ Physiol 292(6):H2921?2926","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"7902_CR4","doi-asserted-by":"publisher","first-page":"H771","DOI":"10.1152\/ajpheart.00711.2009","volume":"298","author":"JB Rose","year":"2010","unstructured":"Rose JB, Naydenova Z, Bang A, Eguchi M, Sweeney G, Choi DS, Hammond JR, Coe IR (2010) Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection. Am J Physiol Heart Circ Physiol 298(3):H771?777","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"48","key":"7902_CR5","doi-asserted-by":"publisher","first-page":"50042","DOI":"10.1074\/jbc.M407913200","volume":"279","author":"K Engel","year":"2004","unstructured":"Engel K, Zhou M, Wang J (2004) Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279(48):50042?50049","journal-title":"J Biol Chem"},{"issue":"5","key":"7902_CR6","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1074\/jbc.M112.436972","volume":"288","author":"H Duan","year":"2013","unstructured":"Duan H, Wang J (2013) Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene. J Biol Chem 288(5):3535?3544","journal-title":"J Biol Chem"},{"issue":"10","key":"7902_CR7","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1124\/dmd.107.015495","volume":"35","author":"M Zhou","year":"2007","unstructured":"Zhou M, Xia L, Wang J (2007) Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine. Drug Metab Dispos 35(10):1956?1062","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"7902_CR8","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1161\/01.RES.0000238359.18495.42","volume":"99","author":"K Barnes","year":"2006","unstructured":"Barnes K, Dobrzynski H, Foppolo S, Beal PR, Ismat F, Scullion ER, Sun L, Tellez J, Ritzel MW, Claycomb WC, Cass CE, Young JD, Billeter-Clark R, Boyett MR, Baldwin SA (2006) Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. Circ Res 99(5):510?519","journal-title":"Circ Res"},{"issue":"1","key":"7902_CR9","doi-asserted-by":"publisher","first-page":"13555","DOI":"10.1038\/s41598-019-49929-w","volume":"9","author":"D Tandio","year":"2019","unstructured":"Tandio D, Vilas G, Hammond JR (2019) Bidirectional transport of 2-chloroadenosine by equilibrative nucleoside transporter 4 (hENT4): Evidence for allosteric kinetics at acidic pH. Sci Rep 9(1):13555","journal-title":"Sci Rep"},{"key":"7902_CR10","doi-asserted-by":"publisher","first-page":"115408","DOI":"10.1016\/j.taap.2021.115408","volume":"414","author":"CL Peng","year":"2021","unstructured":"Peng CL, Jiang N, Zhao JF, Liu K, Jiang W, Cao PG (2021) Metformin relieves H\/R-induced cardiomyocyte injury through miR-19a\/ACSL axis - possible therapeutic target for myocardial I\/R injury. Toxicol Appl Pharmacol 414:115408","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"7902_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijcard.2006.03.044","volume":"116","author":"GP Leung","year":"2007","unstructured":"Leung GP, Tse CM, Man RY (2007) Characterization of adenosine transport in H9c2 cardiomyoblasts. Int J Cardiol 116(2):186?193","journal-title":"Int J Cardiol"},{"issue":"12","key":"7902_CR12","doi-asserted-by":"publisher","first-page":"8375","DOI":"10.1074\/jbc.275.12.8375","volume":"275","author":"JL Ward","year":"2000","unstructured":"Ward JL, Sherali A, Mo ZP, Tse CM (2000) Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem 275(12):8375?8381","journal-title":"J Biol Chem"},{"key":"7902_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/B978-0-12-394309-5.00006-7","volume":"298","author":"T Kalogeris","year":"2012","unstructured":"Kalogeris T, Baines CP, Krenz M, Korthuis RJ (2012) Cell biology of ischemia\/reperfusion injury. Int Rev Cell Mol Biol 298:229?317","journal-title":"Int Rev Cell Mol Biol"},{"issue":"3","key":"7902_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1021\/jm00081a001","volume":"35","author":"KA Jacobson","year":"1992","unstructured":"Jacobson KA, van Galen PJ, Williams M (1992) Adenosine receptors: Pharmacology, structure activity relationships, and therapeutic potential. J Med Chem 35(3):407?421","journal-title":"J Med Chem"},{"issue":"16","key":"7902_CR15","doi-asserted-by":"publisher","first-page":"15880","DOI":"10.1074\/jbc.M414337200","volume":"280","author":"SA Baldwin","year":"2005","unstructured":"Baldwin SA, Yao SY, Hyde RJ, Ng AM, Foppolo S, Barnes K, Ritzel MW, Cass CE, Young JD (2005) Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem 280(16):15880?15887","journal-title":"J Biol Chem"},{"issue":"11","key":"7902_CR16","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.bcp.2013.08.063","volume":"86","author":"C Wang","year":"2013","unstructured":"Wang C, Lin W, Playa H, Sun S, Cameron K, Buolamwini JK (2013) Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4). Biochem Pharmacol 86(11):1531?1540","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"7902_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1476-5381.1991.tb12442.x","volume":"104","author":"FE Parkinson","year":"1991","unstructured":"Parkinson FE, Clanachan AS (1991) Adenosine receptors and nucleoside transport sites in cardiac cells. Br J Pharmacol 104(2):399?405","journal-title":"Br J Pharmacol"},{"issue":"5","key":"7902_CR18","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1139\/o02-143","volume":"80","author":"N Chaudary","year":"2002","unstructured":"Chaudary N, Shuralyova I, Liron T, Sweeney G, Coe IR (2002) Transport characteristics of HL1 cells: A new model for the study of adenosine physiology in cardiomyocytes. Biochem Cell Biol 80(5):655?665","journal-title":"Biochem Cell Biol"},{"issue":"5","key":"7902_CR19","doi-asserted-by":"publisher","first-page":"e14395","DOI":"10.14814\/phy2.14395","volume":"8","author":"R Wei","year":"2020","unstructured":"Wei R, Gust SL, Tandio D, Maheux A, Nguyen KH, Wang J, Bourque S, Plane F, Hammond JR (2020) Deletion of murine slc29a4 modifies vascular responses to adenosine and 5-hydroxytryptamine in a sexually dimorphic manner. Physiol Rep 8(5):e14395","journal-title":"Physiol Rep"},{"issue":"10","key":"7902_CR20","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1124\/dmd.110.032987","volume":"38","author":"M Zhou","year":"2010","unstructured":"Zhou M, Duan H, Engel K, Xia L, Wang J (2010) Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations. Drug Metab Dispos 38(10):1798?1805","journal-title":"Drug Metab Dispos"},{"issue":"21","key":"7902_CR21","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1161\/CIRCULATIONAHA.104.528133","volume":"112","author":"P Bianchi","year":"2005","unstructured":"Bianchi P, Kunduzova O, Masini E, Cambon C, Bani D, Raimondi L, Seguelas MH, Nistri S, Colucci W, Leducq N, Parini A (2005) Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation 112(21):3297?3305","journal-title":"Circulation"},{"issue":"3","key":"7902_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/YIC.0b013e32835d735d","volume":"28","author":"C Andrade","year":"2013","unstructured":"Andrade C, Kumar CB, Surya S (2013) Cardiovascular mechanisms of SSRI drugs and their benefits and risks in ischemic heart disease and heart failure. Int Clin Psychopharmacol 28(3):145?155","journal-title":"Int Clin Psychopharmacol"},{"key":"7902_CR23","doi-asserted-by":"crossref","unstructured":"Mercy MD, Nesti C, Palenzuela L, Winsome F, Walker E, Hernandez L, Protas (2005) Michio Hirano, Nithila D Isaac. Novel cell lines derived from adult human ventricular cardiomyocytes. J Mol Cell Cardiol. 39(1):133?147","DOI":"10.1016\/j.yjmcc.2005.03.003"},{"key":"7902_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.yjmcc.2021.12.007","volume":"165","author":"Z On\u00f3di","year":"2022","unstructured":"On\u00f3di Z, Visnovitz T, Kiss B, Hambalk\u00f3 S, Koncz A, \u00c1gg B, V\u00e1radi B, T\u00f3th V, Nagy RN, Gergely TG, Gerg\u0151 D, Makkos A, Pelyhe C, Varga N, Re? D, Ap\u00e1ti \u00c1, Leszek P, Kov\u00e1cs T, Nagy N, Ferdinandy P, Buz\u00e1s EI, G?rbe A, Giricz Z, Varga ZV (2022) Systematic transcriptomic and phenotypic characterization of human and murine cardiac myocyte cell lines and primary cardiomyocytes reveals serious limitations and low resemblances to adult cardiac phenotype. J Mol Cell Cardiol 165:19?30","journal-title":"J Mol Cell Cardiol"},{"key":"7902_CR25","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/ejn.13968","volume":"48","author":"TL Gilman","year":"2018","unstructured":"Gilman TL, George CM, Vitela M, Herrera-Rosales M, Basiouny MS, Koek W, Daws LC (2018) Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviours. Eur J Neurosci 48:1706?1716","journal-title":"Eur J Neurosci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07902-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07902-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07902-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T11:06:48Z","timestamp":1667128008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07902-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["7902"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07902-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"assertion":[{"value":"13 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state no conflict of interest from a financial or commercial standpoint.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}